Trials / Completed
CompletedNCT00190918
A Trial for Patients With Gestational Trophoblastic Disease
A Phase II Trial of Pemetrexed (Alimta) in the Treatment of Recurrent or Persistent Low Risk Gestational Trophoblastic Tumor
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This phase II study is evaluating the activity of Pemetrexed in patients diagnosed with low risk Gestational Trophoblastic Tumor (GTT) that have failed prior treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pemetrexed |
Timeline
- Start date
- 2006-07-01
- Completion
- 2007-07-01
- First posted
- 2005-09-19
- Last updated
- 2007-08-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00190918. Inclusion in this directory is not an endorsement.